Editing Talk:1217: Cells

Jump to: navigation, search
Ambox notice.png Please sign your posts with ~~~~

Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.

The edit can be undone. Please check the comparison below to verify that this is what you want to do, and then save the changes below to finish undoing the edit.
Latest revision Your text
Line 1: Line 1:
 
One can test the cytotoxicity (the ability to kill cells) on a petri-dish level for cancer cells and healthy cells separately. However, this is often not done, knowingly neglecting selectivity issues one could face if the tests were done. This should be included in the explanation. The part that is written in the moment mainly explains the title text. [[Special:Contributions/130.60.152.125|130.60.152.125]] 08:34, 27 May 2013 (UTC)
 
One can test the cytotoxicity (the ability to kill cells) on a petri-dish level for cancer cells and healthy cells separately. However, this is often not done, knowingly neglecting selectivity issues one could face if the tests were done. This should be included in the explanation. The part that is written in the moment mainly explains the title text. [[Special:Contributions/130.60.152.125|130.60.152.125]] 08:34, 27 May 2013 (UTC)
  
βˆ’
:Sorry to correct you. Toxicity is tested for both, healthy cells an cancer cells. But as the targets for drugs are often present in both celltypes, the drug itself affect also both cells. Then you have to choose between certain death by cancer in short time and maybe death or side effects in the long row but survival. It's replacing one evil with another. Only very modern anticancer drugs (e.g. Gleevec) are selective enough to target (mostly) only cancer cells. The drawback is, as cancer in different people is not the same but different cells, you would need different drugs for everybodey affected. One way here lies in the personalized medicine, but that is very expensive...
+
  Sorry to correct you. Toxicity is tested for both, healthy cells an cancer cells. But as the targets for drugs are often present in both celltypes, the drug itself affect also both cells. Then you have to choose between certain death by cancer in short time and maybe death or side effects in the long row but survival. It's replacing one evil with another. Only very modern anticancer drugs (e.g. Gleevec) are selective enough to target (mostly) only cancer cells. The drawback is, as cancer in different people is not the same but different cells, you would need different drugs for everybodey affected. One way here lies in the personalized medicine, but that is very expensive...
 
[[Special:Contributions/195.37.27.58|195.37.27.58]] 10:05, 27 May 2013 (UTC)Richard
 
[[Special:Contributions/195.37.27.58|195.37.27.58]] 10:05, 27 May 2013 (UTC)Richard
  

Please note that all contributions to explain xkcd may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see explain xkcd:Copyrights for details). Do not submit copyrighted work without permission!

To protect the wiki against automated edit spam, we kindly ask you to solve the following CAPTCHA:

Cancel | Editing help (opens in new window)